Dermatology Doctors in Quincy, MA Accepting Medicare

10 Dermatology doctors found. Showing 1 - 10

Peter C. Young, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1250 Hancock St, Quincy, MA 02169 Phone: 617-774-0820    Fax: 617-774-0832

Stephen Gregory Werth, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 300 Congress St, Suite 408, Quincy, MA 02169 Phone: 617-773-7431    Fax: 617-773-9592

Kenneth M Reed, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 500 Congress St, Suite B1, Quincy, MA 02169 Phone: 617-472-6764

Victoria Kuohung, MD Dermatology Medicare: May Accept Medicare Assignments Practice Location: 1250 Hancock St, Suite 505s, Quincy, MA 02169 Phone: 781-253-7165    Fax: 781-253-7166

Candace Marie Broussard-steinberg, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1250 Hancock St Ste 505s, Quincy, MA 02169 Phone: 781-253-7165    Fax: 781-253-7166

Stephen V. Tang, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1250 Hancock St, Quincy, MA 02169 Phone: 617-774-0820    Fax: 617-774-0832

Elise Bilodeau Mccarthy, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 36 Adams St, Quincy, MA 02169 Phone: 617-773-9805    Fax: 617-474-5400

Steven M Kahn, M.D. Dermatology - Procedural Dermatology Medicare: Not Enrolled in Medicare Practice Location: 500 Congress St, Quincy, MA 02169 Phone: 617-773-7431

Sara Balakrishnan, PA-C Dermatology Medicare: Accepting Medicare Assignments Practice Location: 36 Adams St, Quincy, MA 02169 Phone: 617-773-9805    Fax: 617-472-5400

Katie Brouillard O'brien, NP Dermatology Medicare: Accepting Medicare Assignments Practice Location: 36 Adams Street, Quincy, MA 02169 Phone: 617-773-9805    Fax: 617-472-5400

News Archive

Initial data from Abiomed's Symphony safety trial on chronic heart failure

Abiomed Inc., a leading provider of breakthrough heart support technologies, today announced that the initial clinical data from the safety study for Symphony was presented by Renzo Cecere, M.D., FRCSC, FACS, Associate Professor of Surgery at McGill University, during the late-breaking clinical trials session at the Society of Thoracic Surgeons (STS) 2012 Annual Meeting in Fort Lauderdale, Florida.

New therapeutic options for management of melanoma brain metastases

In a recent article published in MELANOMA RESEARCH and a subsequent commentary in British medical journal THE LANCET, researchers at Moffitt Cancer Center discussed new therapeutic options for the management of melanoma brain metastases. Patients with advanced melanoma are at high risk for developing brain metastases. Once brain metastases are present, these patients tend to have poor outcomes.

Broker websites expand health plan shopping options while glossing over details

Some websites consumers use to buy their own health insurance don't provide full information on plan choices or Medicaid eligibility, and appear to encourage selection of less comprehensive coverage that provides higher commissions to brokers, according to a report released Friday by the left-leaning Center on Budget and Policy Priorities.

Discovery Lab enrolls first patient in phase 2a clinical trial of AEROSURF

Discovery Laboratories, Inc., a specialty biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today reported that the first patient has been enrolled in the next phase of its phase 2a clinical evaluation of AEROSURF, which is designed to evaluate the safety and tolerability of higher and repeat doses of aerosolized KL4 surfactant administered to premature infants 29 to 34 weeks gestational age (GA) who are receiving nasal continuous positive airway pressure (nCPAP) for respiratory distress syndrome (RDS), compared to infants receiving nCPAP alone.

Read more Medical News

› Verified 5 days ago